Uterine Clostridium perfringens infection related to gynecologic malignancy

por Kremer, Kevin M., McDonald, Megan E., Goodheart, Michael J.
Publicado 2017

Malignant struma ovarii with insular carcinoma: A case report and literature review

por Williams, Heather, Salinas, Erin, Savage, Erica, Samuelson, Megan, Goodheart, Michael J.
Publicado 2016

Resection of an endocardial uterine sarcoma metastasis to the tricuspid valve apparatus with valve repair

por Arshava, Andrey E., Isaacson, Alexandra L., Goodheart, Michael J., Bashir, Mohammad A.
Publicado 2023

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer

por Newtson, Andreea, Reyes, Henry, Devor, Eric J., Goodheart, Michael J., Bosquet, Jesus Gonzalez
Publicado 2021

Placenta-Specific Protein 1: A Potential Key to Many Oncofetal-Placental OB/GYN Research Questions

por Devor, Eric J., Reyes, Henry D., Santillan, Donna A., Santillan, Mark K., Onukwugha, Chinenye, Goodheart, Michael J., Leslie, Kimberly K.
Publicado 2014

Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival

por Cardillo, Nicholas, Russo, Douglas, Newtson, Andreea, Reyes, Henry, Lyons, Yasmin, Devor, Eric, Bender, David, Goodheart, Michael J., Gonzalez-Bosquet, Jesus
Publicado 2021

Disparity of ovarian cancer survival between urban and rural settings

por Ulmer, Keely Krolikowski, Greteman, Breanna, Cardillo, Nicholas, Schneider, Anthony, McDonald, Megan, Bender, David, Goodheart, Michael J, Gonzalez Bosquet, Jesus
Publicado 2022

Population Substructure Has Implications in Validating Next-Generation Cancer Genomics Studies with TCGA

por Miller, Marina D., Devor, Eric J., Salinas, Erin A., Newtson, Andreea M., Goodheart, Michael J., Leslie, Kimberly K., Gonzalez-Bosquet, Jesus
Publicado 2019

Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome

por Gonzalez-Bosquet, Jesus, Pedra-Nobre, Silvana, Devor, Eric J., Thiel, Kristina W., Goodheart, Michael J., Bender, David P., Leslie, Kimberly K.
Publicado 2021

Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation

por Gonzalez-Bosquet, Jesus, McDonald, Megan E., Bender, David P., Smith, Brian J., Leslie, Kimberly K., Goodheart, Michael J., Devor, Eric J.
Publicado 2023

Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182

por DEVOR, ERIC J., SCHICKLING, BRANDON M., REYES, HENRY D., WARRIER, AKSHAYA, LINDSAY, BRITTANY, GOODHEART, MICHAEL J., SANTILLAN, DONNA A., LESLIE, KIMBERLY K.
Publicado 2016

Prediction of chemo-response in serous ovarian cancer

por Gonzalez Bosquet, Jesus, Newtson, Andreea M., Chung, Rebecca K., Thiel, Kristina W., Ginader, Timothy, Goodheart, Michael J., Leslie, Kimberly K., Smith, Brian J.
Publicado 2016

Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy

por Lyons, Yasmin A, Reyes, Henry D, McDonald, Megan E, Newtson, Andreea, Devor, Eric, Bender, David P, Goodheart, Michael J, Gonzalez Bosquet, Jesus
Publicado 2020

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence

por Gonzalez-Bosquet, Jesus, Gabrilovich, Sofia, McDonald, Megan E., Smith, Brian J., Leslie, Kimberly K., Bender, David D., Goodheart, Michael J., Devor, Eric
Publicado 2022

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer

por Cardillo, Nicholas, Devor, Eric J., Pedra Nobre, Silvana, Newtson, Andreea, Leslie, Kimberly, Bender, David P., Smith, Brian J., Goodheart, Michael J., Gonzalez-Bosquet, Jesus
Publicado 2022

Using Genomic Variation to Distinguish Ovarian High-Grade Serous Carcinoma from Benign Fallopian Tubes

por Gonzalez-Bosquet, Jesus, Cardillo, Nicholas D., Reyes, Henry D., Smith, Brian J., Leslie, Kimberly K., Bender, David P., Goodheart, Michael J., Devor, Eric J.
Publicado 2022

p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers

por Devor, Eric J., Gonzalez-Bosquet, Jesus, Warrier, Akshaya, Reyes, Henry D., Ibik, Nonye V., Schickling, Brandon M., Newtson, Andreea, Goodheart, Michael J., Leslie, Kimberly K.
Publicado 2017

The Role of LEF1 in Endometrial Gland Formation and Carcinogenesis

por Shelton, Dawne N., Fornalik, Hubert, Neff, Traci, Park, Soo Yeun, Bender, David, DeGeest, Koen, Liu, Xiaoming, Xie, Weiliang, Meyerholz, David K., Engelhardt, John F., Goodheart, Michael J.
Publicado 2012

TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

por BRACHOVA, PAVLA, MUETING, SAMUEL R., CARLSON, MATTHEW J., GOODHEART, MICHAEL J., BUTTON, ANNA M., MOTT, SARAH L., DAI, DONGHAI, THIEL, KRISTINA W., DEVOR, ERIC J., LESLIE, KIMBERLY K.
Publicado 2014

Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer

por McDonald, Megan E., Salinas, Erin A., Devor, Eric J., Newtson, Andreea M., Thiel, Kristina W., Goodheart, Michael J., Bender, David P., Smith, Brian J., Leslie, Kimberly K., Gonzalez-Bosquet, Jesus
Publicado 2019